HAVCR2 and neoplasm: Consistent with these reports, α-PD-L1 antibody treatment alone did not significantly reduce the pulmonary growth of the syngeneic D2.A1 model of MBC, and resulted in high level expression of TIM3 and LAG3 in T-cells from tumor-bearing mice.